Altheos
Signal active
Organization
Contact Information
Overview
Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs.
Altheos, Inc. completed $20MM series A financing in March 2010 led by Bay City Capital with participation from Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor for topical treatment of glaucoma that Altheos licensed from a Japanese pharmaceutical company. The license also includes a series of highly active compounds specifically for topical treatment for glaucoma.
About
Industries
Biotechnology, Health Care, Clinical Trials
Founded
2010
Employees
11-50
Headquarters locations
South San Francisco, California, United States, North America
Social
Profile Resume
Altheos headquartered in United States, North America, operates in the Biotechnology, Health Care, Clinical Trials sector. The company focuses on Biotechnology and has secured $780.0M in funding across 24 round(s). With a team of 11-50 employees, Altheos is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Altheos, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
5
Lead Investors
0
Total Funding Amount
$32.5M
Details
2
Altheos has raised a total of $32.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2012 | Early Stage Venture | 12.5M | ||
| 2010 | Early Stage Venture | 20.0M |
Investors
Altheos is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Atheneos Ventures | - | FUNDING ROUND - Atheneos Ventures | 20.0M |
| Peter Bisgaard | - | FUNDING ROUND - Peter Bisgaard | 20.0M |
| Altheos | - | FUNDING ROUND - Altheos | 20.0M |
| Novo Holdings | - | FUNDING ROUND - Novo Holdings | 20.0M |